The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 10.32 — safe zoneOK
- Earnings-manipulation signal · Beneish M -2.30 — no flag raisedOK
- Earnings quality 94/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2024, as BIOLIFE SOLUTIONS INC reports it. History and quarterly detail are in the app.
- Product$76.0M
- Product Cell Processing$73.4M
- Rental Revenue$6.1M
- Rental Evo And Thaw$6.1M
- Product Evo And Thaw$2.6M
Leadership changes
From BIOLIFE SOLUTIONS INC's own filings, the day they're filed.
- Catherine Coste · directors · departureeff. 2025-03-18
- Tony J. Hunt · Chairman · appointmenteff. 2025-01-02
Latest filings
- 8-K · Company announcement2026-06-03
- 10-Q · Quarterly report2026-05-07
- 8-K · Company announcement2026-05-07
- 8-K · Company announcement2026-03-02
- 8-K · Company announcement2026-02-26
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about BIOLIFE SOLUTIONS INC, every answer cited🔒
- The Intelligence Brief — added when BIOLIFE SOLUTIONS INC's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.